...
首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease
【24h】

Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease

机译:新型MicroRNA-455-3P及其对阿尔茨海默病的异常应用处理和淀粉样蛋白β毒性的保护作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of our study is to understand the protective role of miR-455-3p against abnormal amyloid precursor protein (APP) processing, amyloid beta (A beta) formation, defective mitochondrial biogenesis/dynamics and synaptic damage in AD progression. In-silico analysis of miR-455-3p has identified the APP gene as a putative target. Using mutant APP cells, miR-455-3p construct, biochemical and molecular assays, immunofluorescence and transmission electron microscopy (TEM) analyses, we studied the protective effects of miR-455-3p on 1) APP regulation, amyloid beta (A beta)(1-40) & (1-42) levels, mitochondrial biogenesis & dynamics; 3) synaptic activities and 4) cell viability & apoptosis. Our luciferase reporter assay confirmed the binding of miR-455-3p at the 3'UTR of APP gene. Immunoblot, sandwich ELISA and immunostaining analyses revealed that the reduced levels of the mutant APP, A beta(1-40) & A beta(1-42), and C99 by miR-455-3p. We also found the reduced levels of mRNA and proteins of mitochondrial biogenesis (PGC1 alpha, NRF1, NRF2, and TFAM) and synaptic genes (synaptophysin and PSD95) in mutant APP cells; on the other hand, mutant APP cells that express miR-455-3p showed increased mRNA and protein levels of biogenesis and synaptic genes. Additionally, expression of mitochondrial fission proteins (DRP1 and FIS1) were decreased while the fusion proteins (OPA1, Mfn1 and Mfn2) were increased by miR-455-3p. Our TEM analysis showed a decrease in mitochondria number and an increase in the size of mitochondrial length in mutant APP cells transfected with miR-455-3p. Based on these observations, we cautiously conclude that miR-455-3p regulate APP processing and protective against mutant APP-induced mitochondrial and synaptic abnormalities in AD.
机译:我们研究的目的是了解MIR-455-3P免受异常淀粉样蛋白前体蛋白(APP)处理,淀粉样蛋白β(Aβ)形成,缺陷的线粒体生物发生/动力学和突触损伤在AD进展中的保护作用。 MIR-455-3P的硅片分析已将APP基因鉴定为推定目标。使用突变体App细胞,MiR-455-3P构建体,生物化学和分子测定,免疫荧光和透射电子显微镜(TEM)分析,我们研究了miR-455-3p对1)应用调节,淀粉样蛋白β(β)的保护作用(1-40)&(1-42)水平,线粒体生物发生和动力学; 3)突触活动和4)细胞活力和凋亡。我们的荧光素酶报告器测定证实了APP基因3'UTR的miR-455-3p的结合。免疫印迹,夹心ELISA和免疫染色分析显示,突变APP,β(1-40)和β(1-42)的水平降低,MIR-455-3P的β(1-42)和C99。我们还发现在突变应用程序单元中的线粒体生物发生(PGC1α,NRF1,NRF2和TFAM)和突触基因(Sypaptophysin和PSD95)的降低的mRNA和蛋白水平;另一方面,表达miR-455-3p的突变映对细胞显示出增加的生物发生和突触基因的mRNA和蛋白质水平。另外,在MiR-455-3P增加融合蛋白(OPA1,MFN1和MFN2)的同时降低了线粒体裂变蛋白(DRP1和FIS1)的表达。我们的TEM分析显示线粒体数量减少,并在用miR-455-3p转染的突变体映射细胞中的线粒体长度尺寸的增加。基于这些观察,我们谨慎得出结论,MIR-455-3P调节应用处理和保护突变体诱导的广告中的线粒体和突触异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号